ABSTRACT
INTRODUCTION
Site-directed mutagenesis is a valuable tool for the study of DNA function and protein structure and function. A number of different mutagenesis methods have been reported (18, 21) . Most site-directed in vitro mutagenesis methods hybridize a target DNA with a mutagenic oligonucleotide that is complementary to the target template except for a region of mismatch that contains the desired mutation. The mutagenic oligonucleotide is used to prime DNA synthesis of the mutant strand to create a heteroduplex of wild-type and mutant sequences. Due to the semi-conservative mode of DNA replication, when transformed into a cell and replicated, the theoretical yield of mutants from the heteroduplex is 50%. In practice, however, the mutant yield from such transformations is often only a few percent. This is assumed to be due to such factors as (i) incomplete in vitro polymerization, (ii) primer displacement by the DNA polymerase used in the fill-in reaction and (iii) in vivo host-directed mismatch repair mechanisms that favor repair of the unmethylated newly synthesized DNA strand (7) . For this reason, site-directed mutagenesis procedures must utilize a selection method to obtain useful mutagenesis efficiencies.
Plasmid vectors contain a number of potential targets that can be used as a selection for the newly synthesized mutant DNA strand. Some mutagenesis methods such as described by Kunkle (8) utilize a DNA template containing deoxyuracil. The template is selectively degraded by subsequent growth in a strain containing deoxyuracil glycosylase. Other techniques incorporate unnatural nucleotides into the newly synthesized strand to confer resistance to in vitro digestion with nucleases (17) . Still other methods take advantage of hemimethylation (20) or destruction of a unique restriction site (5,10) followed by restriction digestion to degrade the template strand and the wild-type plasmid. Some of these methods require numerous DNA manipulation steps, and the efficiency of the selection is dependent on the efficiency of the enzymes involved.
Another potential target for selection of the mutant strand is the antibiotic resistance, typically ampicillin resistance, encoded on plasmid vectors. A selection oligonucleotide encoding alterations to the existing antibiotic resistance gene can be incorporated into the newly synthesized DNA strand along with the mutagenic oligonucleotide. Selection for the mutant strand based on antibiotic resistance encoded by the selection oligonucleotide provides a convenient and efficient positive selection that is not dependent on the efficiency of an in vitro selection.
We have developed a novel antibiotic selection method for use in site-directed mutagenesis that involves modification of the substrate specificity of TEM-1 β -lactamase. A Basic Local Alignment Search Tool (BLAST) search of the vector database at the National Center for Biotechnology (NCBI; http://www. ncbi.nlm.nih.gov/BLAST/ ) revealed that the TEM-1 sequence is present in over 90% of the commonly used cloning vectors. Numerous mutations have been identified in the TEM-1 β -lactamase that alter the substrate specificity of the enzyme and result in increased hydrolytic activity of the enzyme against extended spectrum β -lactam antibiotics (2, 3, 6, 9, (11) (12) (13) (14) 16, 20) . This increased activity results in increased resistance specific to cells expressing the mutant enzyme and is the basis of the selection strategy.
MATERIALS AND METHODS
All reagents, cells, oligonucleotides and plasmids used in the mutagenesis reactions were obtained from Promega (Madison, WI, USA), except for Bluescript ® II KS(+), XL1-Blue and SURE ® cells, which were obtained from Stratagene (La Jolla, CA, USA). Ampicillin, ceftriaxone, and cefotaxime were purchased from Sigma Chemical (St. Louis, MO, USA). All DNA templates contained the TEM-1 β -lactamase gene as assessed by a search of the vector database at NCBI.
The antibiotic selection mixture is composed of 100 µ g/mL ampicillin, 0.5 µ g/mL cefotaxime and 0.5 µ g/mL ceftriaxone in 100 mM potassium phosphate, pH 6.0. The mixture is filter-sterilized, aliquoted and stored at -20°C. Accelerated stability testing indicates the antibiotic mixture is stable at -20°C for up to 1 year. Freeze-thaw cycles are not recommended, as this may affect the efficacy of the mixture.
Mutagenesis reactions were performed using either single-stranded (ss) or double-stranded (ds) DNA templates ( Figure 1 ). Single-stranded templates were prepared by Maniatis's method (15) . dsDNA plasmid templates were alkaline-denatured before hybridization by treatment with 2 M NaOH for 5 min at room temperature then neutralized with 2 M ammonium acetate, pH 4.6. Selection oligonucleotides and mutagenic oligonucleotides were added to denatured templates at an oligonucleotide:template molar ratio of 5:1 and 25:1, respectively, in the presence of 20 mM Tris-HCl, pH 7.5, 10 mM MgCl 2 and 50 mM NaCl. Hybridization reactions were heated to 75°C for 5 min and Sho r t Technical Repo r t s then cooled to 37°C at 1.5°C per min using a Model 480 Thermal Cycler (Perkin-Elmer, Norwalk, CT. USA). T4 DNA ligase (1-3 U) and T4 DNA polymerase (5-10 U) were added in the presence of synthesis buffer (10 mM Tris-HCl, pH 7.5, 0.5 mM dNTPs, 1 mM ATP, 2 mM dithiothreitol [DTT]), and the reaction was incubated at 37°C for 90 min.
The synthesis reaction (1.5 µ L) was transformed into BMH71-18 mut S, a mismatch repair deficient strain of E. coli , which avoids selection against the desired mutation. The transformed cells were grown in an optimized mixture of extended-spectrum cephalosporins to effectively select only those cells with altered resistance, some of which contain the desired mutation. Concentrations of ceftriaxone and cefotaxime used in the antibiotic selection mixture were determined from minimal inhibitory concentration (MIC) titrations performed on BMH71-18 mut S and JM109 host strains containing several common cloning vectors. Optimal concentrations of the cephalosporins were determined to be 0.5 µ g/mL for both ceftriaxone and cefotaxime for growth of cells containing high-copy-number plasmids. Lower concentrations of the antibiotics may be required to maintain growth of cells with low levels of β -lactamase expression (i.e., low-copy-number plasmids). Unlike ampicillin, the cephalosporins in this mixture can inhibit growth of resistant cells when provided in excess. Although ampicillin was included in the antibiotic mixture at 100 µ g/mL to select against nontransformed cells, it is not strictly required for efficient selection of the desired mutant. A subsequent strain transfer into JM109 and growth in the antibiotic selection mixture is neces974BioTechniques
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Native
The sequence of the selection oligonucleotide is shown relative to the native β -lactamase sequence. The oligonucleotide hybridizes to residues 233-245 [using the numbering system of Ambler et al. (1)]. Substitutions are in boldface. Table 1 . Sequence Alignment of the Cephalosporin Selection Oligonucleotide with the Native β β -Lactamase Sequence sary to ensure proper clonal segregation and allow for long-term maintenance of the mutant plasmid. Mutagenesis efficiencies were assessed by either blue/white screening on isopropyl-β -D -thiogalactopyranoside (IPTG)/5-bromo-4-chloro-3-indolyl-β -D -galactopyranoside (X-gal) plates, or restriction digestion followed by gel electrophoresis or antibiotic resistance following replica plating. Large insertions or deletions were confirmed by size.
RESULTS AND DISCUSSION
A series of reported mutations in β -lactamase were evaluated for potential use in a selection strategy. E104K and R164S are single amino acid substitutions, which have been shown to enhance enzymatic activity against the extended-spectrum cephalosporins, ceftazidime and cefotaxime (11,14,19) . M69L increases the resistance to clavulanic acid (3) . Although each of these single mutations confers an increase in cephalosporin resistance, a better selection was provided by the triple mutant G238S:E240K:R241G. [Residues 238, 240 and 241 are adjacent in the β -lactamase sequence, but are numbered according to the system of Ambler (1)].
G238S:E240K:R241G displays increased resistance to ceftazidime, cefotaxime (2) and ceftriaxone. This mutation has several advantages for use in the selection strategy. It provides a higher level of resistance to cefotaxime and ceftriaxone than single substitutions as determined by minimal inhibitory concentration titrations. Additionally, all three substitutions can be encoded on a single oligonucleotide. The fact that three residues are mutated reduces the chance of spontaneous resistance to selection antibiotic levels that might occur with a single point mutation. Moreover, the triple mutant also confers sufficient resistance for selection in most of the common E. coli host strains tested. Strains tested include JM109, ES1301, HB101, DH5 α™, XL1-Blue and SURE (data not shown). Table 1 shows the sequence of the selection oligonucleotide encoding G238S:E240K:R241G aligned with the wild-type β -lactamase sequence.
The mutations outlined in Table 2 were designed to assess mutagenesis efficiencies for various types of mutations using cephalosporin specificity as a selection. Some of the reactions were performed on both single-stranded and double-stranded templates to compare efficiencies. We attempted to generate difficult mutations including large insertions (B) and multiple-site substitutions (H). The generation of large insertions or large deletions and multiplesite substitutions is often restricted by the intrinsic properties of the oligonucleotide primer and the target sequence. Base composition and formation of secondary structure in large primers (or sets of primers) can influence efficient hybridization to the target and require Primer to template molar ratios were 5:1 for the β -lactamase selection oligonucleotide and 25:1 for each mutagenic oligonucleotide. Hybridization conditions for all mutagenic reactions were 75°C for 5 min followed by cooling at 1.5°C/min. Synthesis reactions were performed at 37°C for 90 min. Reactions A, E and G were screened by blue/white screening on plates containing IPTG and X-gal. Reaction F was screened by replica plating on plates containing tetracycline. Reactions B, C, D and H were screened by restriction digest analysis followed by gel electrophoresis. (ND: not determined; dsDNA: double-stranded DNA; ssDNA: single-stranded DNA. Mutagenesis reactions were carried out essentially as described in Table 2 except only double-stranded template was used. Clones from reactions J and K were screened by restriction digestion followed by gel electrophoresis. Clones from reaction I were screened by sequence analysis. template pair. In addition to single mutations, we were able to generate multiple-site mutations using multiple mutagenic oligonucleotides. In reaction H, five separate mutagenic oligonucleotides encoding novel restriction sites were introduced into pGEM ® -7Zf(+) (Promega) with overall 30% efficiency. One disadvantage to this method is that it is limited to vectors that contain ampicillin markers. Additionally, a second round of mutagenesis or "toggling" between ampicillin and cephalosporin resistances is not possible, as both the mutant and the wild-type phenotypes retain resistance to ampicillin alone. However, our results indicate that the altered β -lactamase selection strategy is an effective method for selection and enrichment of desired mutations of many types.
We believe this new selection strategy has several advantages over current approaches to oligonucleotide-directed mutagenesis. The method relies upon positive antibiotic selection of the mutant strand, which consistently results in a high proportion of mutants. An additional advantage is that the selection can be applied to any vector that carries the β -lactamase gene, allowing mutagenesis to be performed without sub-cloning into a specialized vector. Moreover, mutagenesis reactions can be performed using dsDNA templates without the need to generate ssDNA. Finally, the procedure uses high fidelity T4 DNA polymerase, which reduces unwanted secondary mutations that are often encountered in PCR-based mutagenesis.
